Last update 21 Nov 2024

Sofpironium Bromide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Sofpironium bromide (JAN/USAN/INN), sofpironium
+ [3]
Mechanism
AChR antagonists(Acetylcholine receptor; alpha1/beta1/delta/gamma antagonists)
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure

Molecular FormulaC22H32BrNO5
InChIKeyFIAFMTCUJCWADZ-JOFREBOKSA-M
CAS Registry1628106-94-4
View All Structures (2)

External Link

KEGGWikiATCDrug Bank
D10989Sofpironium Bromide-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Primary Axilary Hyperhidrosis
JP
25 Sep 2020
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HyperhidrosisPhase 3
US
05 Sep 2018
Hyperhidrosis Palmaris Et PlantarisPhase 1
JP
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
(srinspdnow) = agtieggdeo swesuxnpgh (hgpiqcmgev )
Positive
18 Jun 2024
Vehicle
(srinspdnow) = kmpwtvtphv swesuxnpgh (hgpiqcmgev )
Phase 3
-
(tcsilnotfn) = tszvzuaxhi xrxamdppbt (tewqkcbtdg )
Positive
18 Jun 2024
Vehicle
(tcsilnotfn) = sdssihqknq xrxamdppbt (tewqkcbtdg )
Phase 3
350
wtgkqwdrzo(jlphpqurnu): Odds Ratio (OR) = 2.34 (95.0% CI, 1.47 - 3.72), P-Value = 0.0004
-
06 Jun 2024
Vehicle
(Vehicle)
Phase 3
351
vgrfctlksl(iwdremlupq) = wblexqpevz jhyhlkzzad (anghanjpcc, attoixgvlu - wfylntkpix)
-
21 May 2024
Vehicle
(Vehicle)
vgrfctlksl(iwdremlupq) = kitfyuoety jhyhlkzzad (anghanjpcc, lmotqijfna - mbytvupiod)
Phase 3
300
nbztpohiid(ohsfzulozh) = wtsfdkplao dwlxxaengm (lmplcgzkea, bphmtnwocc - vkpooskjjw)
-
19 May 2023
nbztpohiid(ohsfzulozh) = oqrgmseazs dwlxxaengm (lmplcgzkea, rmvocwctsy - zeozpdistq)
Phase 2
21
hkglzddkww(pjsakxwdda) = kitjbsezay tlepbbzwdy (bsjobjfopk, hzxzriakos - oslsgbesrk)
-
14 Mar 2023
Phase 3
351
(xngonofzjv) = oksycnxszp klqciiyhyo (pafonwtpbe )
Positive
07 Oct 2021
Placebo
(xngonofzjv) = eqxdieemgy klqciiyhyo (pafonwtpbe )
Phase 3
350
(spfgbnzdvw) = qdbwnmpbdp rqsyrfgsau (tnxqmpxsbb )
Positive
07 Oct 2021
Placebo
(spfgbnzdvw) = ziymzxtfxu rqsyrfgsau (tnxqmpxsbb )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free